思派健康科技有限公司（00314）于2026年2月6日发布翌日披露报表。公告显示，公司当日回购364,600股普通股，占回购前已发行股份（不包括库藏股）总数0.049%。本次回购价格区间在每股2.29港元至2.38港元，总涉资约86.38万港元。回购后，公司已发行股份总数仍为765,578,114股，其中库藏股增加至27,118,600股。
根据公告，回购权限获批准日期为2025年6月20日，授权回购股份总数为75,022,471股。截至本次回购，公司已累计回购12,938,800股，占授权通过当日已发行股份总数1.725%。公司确认上述交易符合香港联合交易所有限公司证券上市规则及相关法律规定。该公告由公司秘书任娜签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.